Clinical trial Recruiting at 1 site Interventional Ages 50 to 85

Assessing heart health in COVID-19 survivors over 50

Official title: Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE): A Randomised Controlled Trial of the Role of Optimal Cardioprotection Strategies to Prevent Heart Failure

Run by Baker Heart and Diabetes Institute · NCT04983823 · Data updated 2026-11-12

This study is testing a new heart health program for COVID-19 survivors over 50 to see if it can help them improve their heart function and reduce their risk of heart failure.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages50 Years to 85 Years
SexAll
Enrollment820 (estimated)
SponsorBaker Heart and Diabetes Institute
Academic / other
Locations1 site (Melbourne, Victoria)
StatusRecruiting
StartedNovember 18, 2021
Main results expectedJuly 30, 2025
Study endsDecember 30, 2025
Registry record updatedOctober 3, 2025
Trial IDNCT04983823 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals over 50 years old who have a history of COVID-19 infection.

Probably not a fit

Patients with significant heart valve issues, previous heart failure, or other serious health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study aims to identify and improve functional capacity in survivors of COVID-19 who are over 50 years old. Participants will be randomized to a cardio-COVID disease management plan (CC-DMP) that includes VO2 testing and imaging to detect reduced functional capacity and subclinical left ventricular dysfunction. The program will also involve clinical reviews for optimal risk factor control and exercise interventions over a 24-month period. The study seeks to demonstrate the feasibility of this approach in reducing heart failure risk among COVID-19 survivors.

Why it matters

Potential benefit: If successful, this study could lead to improved heart health and reduced risk of heart failure in COVID-19 survivors.

How similar studies have gone: Other studies have shown promising results in managing cardiovascular health in COVID-19 survivors, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. History of COVID-19 infection
2. Live within a geographically accessible area for follow-up

Exclusion Criteria:

1. Valvular stenosis or regurgitation of \>moderate severity
2. History of previous heart failure (baseline New York Heart Association (NYHA) classification \>2)
3. Inability to acquire interpretable images (identified from baseline echo)
4. Contraindications to beta blockers or angiotensin-converting enzyme inhibitors
5. Oncologic (or other) life expectancy \<12 months or any other medical condition (including pregnancy) that results in the belief (deemed by the Chief Investigators) that it is not appropriate for the patient to participate in this trial
6. Already taking both angiotensin converting enzyme inhibitors/ angiotensin receptor blockers and beta blockers, or intolerance (or allergy) to both.
7. Mobility impairment that would impact participants' ability to perform exercise
8. Unable to provide written informed consent to participate in this study

Where it's running

  • Baker Heart and Diabetes Institute
    Melbourne, Victoria, Australia
    Recruiting

Study contacts

  • Principal investigator: Thomas H Marwick, MD,PhD,MPH — Baker Heart and Diabetes Institute
  • Study coordinator: Joel Smith, MSc
  • Email: joel.smith@baker.edu.au
  • Phone: +61385321964

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.